Orphan Therapeutics Accelerator Announces Foundational Partnerships
Founding Members Chiesi, BIAL Lead Initial Funding;
Landmark Bio, Uncommon Cures Join Clinical Development Network;
DVLP Medicines, Vibe Bio to Provide Integrated AI-based Solutions
How to improve biopharma business development with AI-powered due diligence
Biopharma business development and scientific teams are under a lot of pressure to identify the next big program for their indication and strategy.
